|
Flores-Blanco P., López-Cuenca Á., Januzzi J., Marín F., Sánchez-Martínez M., Quintana-Giner M., Romero-Aniorte A., Valdés M., Manzano-Fernández S. Major bleeding risk prediction using Chronic Kidney Disease Epidemiology Collaboration and Modification of Diet in Renal Disease equations in acute coronary syndrome. European Journal of Clinical Investigation. 1 April 2015. 45:385-393. 10.1111/eci.12418
AÑO: 2015; IF: 2.687
|
25661774
|
Hernández-Romero D, Jover E, Martínez CM, Andreu-Cayuelas JM, Orenes-Piñero E, Romero-Aniorte AI, Casas T, Cánovas S, Montero-Argudo JA, Valdés M, de la Morena G, Marín F. TWEAK and NT-proBNP levels predict exercise capacity in hypertrophic cardiomyopathy. Eur J Clin Invest. 2015 Feb;45(2):179-86. doi: 10.1111/eci.12394. PubMed PMID: 25524713.
AÑO: 2015; IF: 2.687
|
|
Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV, Lawson FC, Ping L, Wei X, Lewis EF, Maggioni AP, McMurray JJ, Probstfield JL, Riddle MC, Solomon SD, Tardif JC; ELIXA Investigators.. Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome. N Engl J Med. 2015 Dec 3;373(23):2247-57. doi: 10.1056/NEJMoa1509225. PubMed PMID: 26630143.
AÑO: 2015; IF: 59.558
|
|
Orenes-Piñero E, Valdés M, Lip GY, Marín F. A comprehensive insight of novel antioxidant therapies for atrial fibrillation management. Drug Metab Rev. 2015 Aug;47(3):388-400. doi: 10.3109/03602532.2015.1077858. PubMed PMID: 27412960.
AÑO: 2015; IF: 4.526
|
|
Bertomeu-González V., Anguita M., Moreno-Arribas J., Cequier Á., Muñiz J., Castillo-Castillo J., Sanchis J., Roldán I., Marin F., Bertomeu-Martínez V. Quality of Anticoagulation with Vitamin K Antagonists. Clinical Cardiology. 1 June 2015. 38:357-364. 10.1002/clc.22397
AÑO: 2015; IF: 2.431
|